IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
10.1038/35074122
Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001). IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature, 410(6832), 1107–1111.

Authors 7
  1. Vijay Shankaran (first)
  2. Hiroaki Ikeda (additional)
  3. Allen T. Bruce (additional)
  4. J. Michael White (additional)
  5. Paul E. Swanson (additional)
  6. Lloyd J. Old (additional)
  7. Robert D. Schreiber (additional)
References 21 Referenced 2,191
  1. Thomas, L. in Cellular and Humoral Aspects of Hypersensitivity States (ed. Lawrence, H. S.) 529–532 (Hoeber, New York, 1959). / Cellular and Humoral Aspects of Hypersensitivity States by L Thomas (1959)
  2. Burnet, F. M. The concept of immunologic surveillance. Prog. Exp. Tumor Res. 13, 1–27 (1970). (10.1159/000386035) / Prog. Exp. Tumor Res. by FM Burnet (1970)
  3. Stutman, O. Spontaneous tumors in nude mice: effect of the viable yellow gene. Exp. Cell. Biol. 47, 129–135 (1979). / Exp. Cell. Biol. by O Stutman (1979)
  4. Stutman, O. Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice. Science 183, 534–536 (1970). (10.1126/science.183.4124.534) / Science by O Stutman (1970)
  5. Stutman, O. Chemical carcinogenesis in nude mice: comparison between nude mice from homozygous and heterozygous matings and effect of age and carcinogen dose. J. Natl Cancer Inst. 2, 353–358 (1979). / J. Natl Cancer Inst. by O Stutman (1979)
  6. Hunig, T. T-cell function and specificity in athymic mice. Immunol. Today 4, 84–87 (1983). (10.1016/0167-5699(83)90125-1) / Immunol. Today by T Hunig (1983)
  7. Maleckar, J. R. & Sherman, L. A. The composition of the T cell receptor repertoire in nude mice. J. Immunol. 138, 3873–3876 (1987). (10.4049/jimmunol.138.11.3873) / J. Immunol. by JR Maleckar (1987)
  8. Dighe, A. S., Richards, E., Old, L. J. & Schreiber, R. D. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors. Immunity 1, 447–456 (1994). (10.1016/1074-7613(94)90087-6) / Immunity by AS Dighe (1994)
  9. Kaplan, D. H. et al. Demonstration of an IFNγ dependent tumor surveillance system in immunocompetent mice. Proc. Natl Acad. Sci. USA 95, 7556–7561 (1998). (10.1073/pnas.95.13.7556) / Proc. Natl Acad. Sci. USA by DH Kaplan (1998)
  10. van den Broek, M. F. et al. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184, 1781–1790 (1996). (10.1084/jem.184.5.1781) / J. Exp. Med. by MF van den Broek (1996)
  11. Smyth, M. J. et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191, 661–668 (2000). (10.1084/jem.191.4.661) / J. Exp. Med. by MJ Smyth (2000)
  12. Smyth, M. J. et al. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192, 755–760 (2000). (10.1084/jem.192.5.755) / J. Exp. Med. by MJ Smyth (2000)
  13. Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855–867 (1992). (10.1016/0092-8674(92)90029-C) / Cell by Y Shinkai (1992)
  14. Meraz, M. A. et al. Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the Jak-STAT signaling pathway. Cell 84, 431–442 (1996). (10.1016/S0092-8674(00)81288-X) / Cell by MA Meraz (1996)
  15. Durbin, J. E., Hackenmiller, R., Simon, M. C. & Levy, D. E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral infection. Cell 84, 443–450 (1996). (10.1016/S0092-8674(00)81289-1) / Cell by JE Durbin (1996)
  16. Old, L. J. & Stockert, E. Immunogenetics of cell surface antigens of mouse leukemia. Annu. Rev. Genet. 17, 127–160 (1977). (10.1146/annurev.ge.11.120177.001015) / Annu. Rev. Genet. by LJ Old (1977)
  17. Marincola, F. M., Jaffee, E. M., Hicklin, D. J. & Ferrone, S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol. 74, 181–273 (2000). (10.1016/S0065-2776(08)60911-6) / Adv. Immunol. by FM Marincola (2000)
  18. Alimonti, J. et al. TAP expression provides a general method for improving the recognition of malignant cells in vivo. Nature Biotechnol. 18, 515–520 (2000). (10.1038/75373) / Nature Biotechnol. by J Alimonti (2000)
  19. Marusina, K., Iyer, M. & Monaco, J. J. Allelic variation in the mouse Tap-1 and Tap-2 transporter genes. J. Immunol. 158, 5251–5256 (1997). (10.4049/jimmunol.158.11.5251) / J. Immunol. by K Marusina (1997)
  20. Huang, S. et al. Immune response in mice that lack the interferon-γ receptor. Science 259, 1742–1745 (1993). (10.1126/science.8456301) / Science by S Huang (1993)
  21. Dighe, A. S. et al. Tissue specific targeting of cytokine unresponsiveness in transgenic mice. Immunity 3, 657–666 (1995). (10.1016/1074-7613(95)90136-1) / Immunity by AS Dighe (1995)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:43 a.m.)
Deposited 2 years, 3 months ago (May 16, 2023, 9:57 p.m.)
Indexed 12 hours, 9 minutes ago (Aug. 30, 2025, 12:24 p.m.)
Issued 24 years, 4 months ago (April 26, 2001)
Published 24 years, 4 months ago (April 26, 2001)
Published Print 24 years, 4 months ago (April 26, 2001)
Funders 0

None

@article{Shankaran_2001, title={IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity}, volume={410}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/35074122}, DOI={10.1038/35074122}, number={6832}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Shankaran, Vijay and Ikeda, Hiroaki and Bruce, Allen T. and White, J. Michael and Swanson, Paul E. and Old, Lloyd J. and Schreiber, Robert D.}, year={2001}, month=apr, pages={1107–1111} }